The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adenoid Vegetations in Adult Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06041074
Recruitment Status : Completed
First Posted : September 18, 2023
Last Update Posted : April 9, 2024
Sponsor:
Information provided by (Responsible Party):
Varazdin General Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
In this observational cross-sectional study " the clinical characteristics of adenoid vegetations in adulthood will be investigated.

Condition or disease
Adenoid Vegetation

Detailed Description:

Adenoid vegetations typically appear in childhood and are well described in this population. However, in adulthood, adenoid vegetations appear rarely and their characteristics have not been described.

The clinical characteristics of adenoid vegetations in adulthood will be investigated, and compared with clinical characteristics of adenoid vegetations in childhood.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 161 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Clinical Characteristics of Adenoid Vegetations in Adult Patients
Actual Study Start Date : September 15, 2023
Actual Primary Completion Date : December 31, 2023
Actual Study Completion Date : December 31, 2023

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Adenoids

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Adults
Patients with adenoid vegetations, 14 years old and older
Children
Patients with adenoid vegetations, 13 years old and younger


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Symptoms [ Time Frame: 2 months ]
    The leading symptom (patient's main complaint, the reason for seeing the doctor) will we recorded for each participant


Secondary Outcome Measures :
  1. Duration of symptoms [ Time Frame: 2 months ]
    The duration of leading symptom (in months) will be recorded for each participant

  2. OTS (otoscopic) [ Time Frame: 2 months ]
    The otoscopic findings will be recorded in both groups

  3. RNS (rhinoscopic) [ Time Frame: 2 months ]
    The rhinoscopic findings will be recorded in both groups

  4. OFS (oropharyngoscopic) [ Time Frame: 2 months ]
    The oropharyngoscopic findings will be recorded in both groups

  5. PRNS (post-rhynoscopic) [ Time Frame: 2 months ]
    The post-rhynoscopic findings will be recorded in both groups

  6. Referring physician [ Time Frame: 2 months ]
    The physician (primary or secondary level) who referred the patient to ENT (Ear Nose and Throat doctor) will be recorded in both groups

  7. PHD ( pathohistological findings) [ Time Frame: 2 months ]
    The pathohistological findings will be recorded in both groups

  8. Surgery [ Time Frame: 2 months ]
    The type of surgery will be recorded in both groups

  9. Outcome [ Time Frame: 2 months ]
    The outcome (the relief of the leading symptom) will be recorded in both groups

  10. Recurrence [ Time Frame: 2 months ]
    The recurrence will be recorded in both groups


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   1 Year to 105 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adult group: All patients aged 14 and more treated for adenoid vegetations in Varazdin General Hospital from 1 January 2013 to 31 December 2019

Children group: All patients aged 13 and less treated for adenoid vegetations in Varazdin General Hospital from 1 January 2019 to 31 December 2019

Criteria

Inclusion Criteria:

  • patient with adenoid vegetations

Exclusion Criteria:

  • other concomitant otorhinolaryngological diagnoses
  • hypertrophy of the tonsils
  • oropharyngeal carcinomas
  • chronic sinuitis
  • allergic rhinitis
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06041074


Locations
Layout table for location information
Croatia
Varazdin General Hospital
Varazdin, Croatia, 42000
Sponsors and Collaborators
Varazdin General Hospital
Investigators
Layout table for investigator information
Principal Investigator: Drazen Shejbal Varazdin General Hospital, Varazdin, Croatia
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Varazdin General Hospital
ClinicalTrials.gov Identifier: NCT06041074    
Other Study ID Numbers: 1968
First Posted: September 18, 2023    Key Record Dates
Last Update Posted: April 9, 2024
Last Verified: September 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No